Linking Opioid Dependent Patients From Inpatient Detoxification to Primary Care
Completed · Not applicable
Conditions studied: Illicit Opioid Drug Use
In brief
The purpose of this study is to determine whether, for individuals in inpatient opioid detoxification, linking to outpatient Suboxone treatment increases treatment adherence and reduces relapse to illicit opioid use.
Key facts
- Study ID
- NCT01751789
- Run by
- Butler Hospital
- People needed
- 335
- Starts
- 2012-10-01
- Expected to finish
- 2018-08-01
- Last updated by the study team
- 2019-01-04
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- 18 years of age or older;
- opioid dependent;
- interested in initiating maintenance buprenorphine treatment;
- opioid positive on urine toxicology;
- willing to establish primary care with a buprenorphine-waivered physician at SSTAR.
You may not qualify if…
- Patients unable to provide informed consent due to acute illness, cognitive impairment, or psychosis;
- probation/parole requirements that might interfere with protocol participation (1% of SSTAR inpatients);
- inability to provide two contact persons to verify location;
- not able to complete assessments in English;
- currently enrolled in a methadone or suboxone maintenance program;
- plans to leave the area within the next 6 months;
- current DSM-IV diagnosis of substance dependence for sedative/hypnotic drugs, cocaine, or alcohol;
- current suicidality on the Modified Scale for Suicidal Ideation;
- chronic pain requiring ongoing opioid use or anticipated major painful event (significant surgical procedure) in the coming 6 months;
- pregnancy;
- history of allergic reaction to buprenorphine or naloxone.
Where it is running
- SSTAR — Fall River, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.